AzurRx BioPharma Inc. (NASDAQ:AZRX) price on Thursday, August 26, rose 0.29% below its previous day’s close as an upside momentum from buyers pushed the stock’s value to $0.62.
A look at the stock’s price movement, the close in the last trading session was $0.62, moving within a range at $0.6102 and $0.64. The beta value (5-Year monthly) was 1.52. Turning to its 52-week performance, $2.63 and $0.52 were the 52-week high and 52-week low respectively. Overall, AZRX moved 10.23% over the past month.
AzurRx BioPharma Inc.’s market cap currently stands at around $63.68 million, with investors looking forward to this quarter’s earnings report slated for Aug 13, 2019. Analysts project the company’s earnings per share (EPS) to be -$0.07, which has seen fiscal year 2021 EPS growth forecast to increase to -$0.36 and about -$0.27 for fiscal year 2022. Per the data, EPS growth is expected to be 68.70% for 2021 and 25.00% for the next financial year.
Revisions could be used as tool to get short term price movement insight, and for the company that in the past seven days was no upward and no downward review(s). Turning to the stock’s technical picture we see that short term indicators suggest on average that AZRX is a 50% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
AZRX’s current price about 5.92% and -8.89% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 50.13, while 7-day volatility ratio is 6.88% and 7.87% in the 30-day chart. Further, AzurRx BioPharma Inc. (AZRX) has a beta value of 1.47, and an average true range (ATR) of 0.06.
In the market, a comparison of AzurRx BioPharma Inc. (AZRX) and its peers suggest the former has performed considerably stronger. Data shows AZRX’s intraday price has changed 0.29% in last session and -18.97% over the past year. Comparatively, Pieris Pharmaceuticals Inc. (PIRS) has moved 2.06% on the day and only 52.22% in the past 12 months. Elsewhere, the overall performance for the S&P 500 and Dow Jones Industrial shows that the indexes are down -0.58% and -0.54% respectively in the last trading.
If we refocus on AzurRx BioPharma Inc. (NASDAQ:AZRX), historical trading data shows that trading volumes averaged 22.6 million over the past 10 days and 3.64 million over the past 3 months. The company’s latest data on shares outstanding shows there are 78.12 million shares.
The 0.97% of AzurRx BioPharma Inc.’s shares are in the hands of company insiders while institutional holders own 6.20% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 2.39 million on May 27, 2021, giving us a short ratio of 1.77. The data shows that as of May 27, 2021 short interest in AzurRx BioPharma Inc. (AZRX) stood at 3.04% of shares outstanding, with shares short rising to 2.29 million registered in Apr 29, 2021. Current price change has pushed the stock -35.68% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the AZRX stock continues to rise going into the next quarter.